Arkolith/Insider Trading/COLL/Form 4

Dreyer Scott

EVP & Chief Commercial OfficerCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Mar 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$625K
Net Open-Market Flow
-$625K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2025Sell(S)19K$30.03$567K104K
Mar 20, 2025Sell(S)2K$30.00$58K122K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-006148) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML